Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

COVID-19 Trial (Pfizer-BioNTech)

Researchers and physicians at Children’s National Hospital have started enrolling children younger than 12 to participate in clinical research trials to evaluate the Pfizer- BioNTech COVID-19 vaccine. This trial is designed to determine how well the vaccine works in children as young as 6 months of age. We expect that enrollment for the trial will occur very quickly, around a few weeks. Please fill out the information form and if your child is eligible for this trial, we will contact you.

For this trial, parents must sign a consent form and bring their child in for the initial shots plus for follow up evaluations. The study includes obtaining blood specimens for COVID antibodies and nasal swabs over the course of approximately 6 months. This study is placebo controlled so some participants will be randomly assigned to receive placebo in place of actual vaccine. Six months after receiving the shots, the participants who received placebo will be given the opportunity to receive the actual vaccine. All the children will have some follow up for about 2 years after vaccination, but the visits will be much less.

Note that we may be able to offer children a chance to participate in future trials for COVID-19 vaccines or other studies, so if your child isn’t chosen for this study we may contact you for other trials.

Register Your Child Now ->